Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.

Autor: Kesavabhotla, Kartik1,2,3,4, Schlaff, Cody D.1,2,3,4, Shin, Benjamin1,2,4, Mubita, Lynn1,4, Kaplan, Rachel5,6, Tsiouris, Apostolos J.6,7, Pannullo, Susan C.1,2,6, Christos, Paul3,4, Lavi, Ehud5,6, Scheff, Ronald6,8, Boockvar, John A.1,2,3,4 jab2029@med.cornell.edu
Zdroj: Journal of Experimental Therapeutics & Oncology. 2012, Vol. 10 Issue 1, p71-81. 11p. 1 Black and White Photograph, 6 Charts, 1 Graph.
Databáze: Academic Search Ultimate